[
  {
    "ts": null,
    "headline": "Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=9330f642ceadb4e4a3cbb37045d4827f31abf1774695389bb642e8a673e30c17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766069404,
      "headline": "Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term",
      "id": 137825568,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=9330f642ceadb4e4a3cbb37045d4827f31abf1774695389bb642e8a673e30c17"
    }
  },
  {
    "ts": null,
    "headline": "BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.",
    "url": "https://finnhub.io/api/news?id=bb835d2d577c046ad55166fdb69128324e00553bf164acacbdd55fb586a82c6b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766058600,
      "headline": "BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry",
      "id": 137821921,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.",
      "url": "https://finnhub.io/api/news?id=bb835d2d577c046ad55166fdb69128324e00553bf164acacbdd55fb586a82c6b"
    }
  }
]